268 related articles for article (PubMed ID: 25993290)
1. Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?
Kroon AM; Taanman JW
Int J Mol Sci; 2015 May; 16(5):11178-95. PubMed ID: 25993290
[TBL] [Abstract][Full Text] [Related]
2. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study.
Mosorin M; Juvonen J; Biancari F; Satta J; Surcel HM; Leinonen M; Saikku P; Juvonen T
J Vasc Surg; 2001 Oct; 34(4):606-10. PubMed ID: 11668312
[TBL] [Abstract][Full Text] [Related]
3. MMP inhibition in abdominal aortic aneurysms. Rationale for a prospective randomized clinical trial.
Thompson RW; Baxter BT
Ann N Y Acad Sci; 1999 Jun; 878():159-78. PubMed ID: 10415728
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content.
Abdul-Hussien H; Hanemaaijer R; Verheijen JH; van Bockel JH; Geelkerken RH; Lindeman JH
J Vasc Surg; 2009 Mar; 49(3):741-9. PubMed ID: 19268776
[TBL] [Abstract][Full Text] [Related]
5. Continuous periaortic infusion improves doxycycline efficacy in experimental aortic aneurysms.
Sho E; Chu J; Sho M; Fernandes B; Judd D; Ganesan P; Kimura H; Dalman RL
J Vasc Surg; 2004 Jun; 39(6):1312-21. PubMed ID: 15192574
[TBL] [Abstract][Full Text] [Related]
6. Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature.
Dodd BR; Spence RA
Curr Vasc Pharmacol; 2011 Jul; 9(4):471-8. PubMed ID: 21595625
[TBL] [Abstract][Full Text] [Related]
7. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.
Curci JA; Mao D; Bohner DG; Allen BT; Rubin BG; Reilly JM; Sicard GA; Thompson RW
J Vasc Surg; 2000 Feb; 31(2):325-42. PubMed ID: 10664501
[TBL] [Abstract][Full Text] [Related]
8. Doxycycline in patients with abdominal aortic aneurysms and in mice: comparison of serum levels and effect on aneurysm growth in mice.
Prall AK; Longo GM; Mayhan WG; Waltke EA; Fleckten B; Thompson RW; Baxter BT
J Vasc Surg; 2002 May; 35(5):923-9. PubMed ID: 12021708
[TBL] [Abstract][Full Text] [Related]
9. Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm.
Baxter BT; Matsumura J; Curci J; McBride R; Blackwelder WC; Liu X; Larson L; Terrin ML;
Contemp Clin Trials; 2016 May; 48():91-8. PubMed ID: 27018941
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells.
Liu J; Xiong W; Baca-Regen L; Nagase H; Baxter BT
J Vasc Surg; 2003 Dec; 38(6):1376-83. PubMed ID: 14681644
[TBL] [Abstract][Full Text] [Related]
11. Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm.
Pini R; Ciavarella C; Faggioli G; Gallitto E; Indelicato G; Fenelli C; Mascoli C; Vacirca A; Gargiulo M; Pasquinelli G
Ann Vasc Surg; 2020 Aug; 67():490-496. PubMed ID: 32173476
[TBL] [Abstract][Full Text] [Related]
12. Interference of doxycycline pretreatment in a model of abdominal aortic aneurysms.
Mata KM; Tefé-Silva C; Floriano EM; Fernandes CR; Rizzi E; Gerlach RF; Mazzuca MQ; Ramos SG
Cardiovasc Pathol; 2015; 24(2):110-20. PubMed ID: 25466491
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.
Lindeman JH; Abdul-Hussien H; van Bockel JH; Wolterbeek R; Kleemann R
Circulation; 2009 Apr; 119(16):2209-16. PubMed ID: 19364980
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential of tetracycline derivatives to suppress the growth of abdominal aortic aneurysms.
Thompson RW; Liao S; Curci JA
Adv Dent Res; 1998 Nov; 12(2):159-65. PubMed ID: 9972142
[TBL] [Abstract][Full Text] [Related]
15. Abdominal aortic aneurysm and cerebral aneurysm present different pathological evolutions and responses to pharmacological therapy.
Zhou X; Ji WJ; Tu Y; Yao M; Li YM
Med Hypotheses; 2007; 68(3):601-6. PubMed ID: 17030100
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation and coexpression of MIF and matrix metalloproteinases in human abdominal aortic aneurysms.
Verschuren L; Lindeman JH; van Bockel JH; Abdul-Hussien H; Kooistra T; Kleemann R
Antioxid Redox Signal; 2005; 7(9-10):1195-202. PubMed ID: 16115023
[TBL] [Abstract][Full Text] [Related]
17. Medical therapy approach for treating abdominal aortic aneurysm.
Rentschler ME; Baxter BT
Vascular; 2007; 15(6):361-5. PubMed ID: 18053421
[TBL] [Abstract][Full Text] [Related]
18. Medical treatment of small abdominal aortic aneurysm.
Assar AN
J Cardiovasc Surg (Torino); 2012 Aug; 53(4):517-25. PubMed ID: 22854530
[TBL] [Abstract][Full Text] [Related]
19. Validated UHPLC-MS/MS method for quantification of doxycycline in abdominal aortic aneurysm patients.
Seelam RR; Terrin M; Hassan HE
Bioanalysis; 2018 Apr; 10(8):527-539. PubMed ID: 29633854
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological approaches to prevent abdominal aortic aneurysm enlargement and rupture.
Rentschler M; Baxter BT
Ann N Y Acad Sci; 2006 Nov; 1085():39-46. PubMed ID: 17182921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
